These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 8880939)
1. The antidepressant drug phenelzine produces antianxiety effects in the plus-maze and increases in rat brain GABA. Paslawski T; Treit D; Baker GB; George M; Coutts RT Psychopharmacology (Berl); 1996 Sep; 127(1):19-24. PubMed ID: 8880939 [TBL] [Abstract][Full Text] [Related]
3. Chronic administration of the antidepressant phenelzine and its N-acetyl analogue: effects on GABAergic function. McKenna KF; McManus DJ; Baker GB; Coutts RT J Neural Transm Suppl; 1994; 41():115-22. PubMed ID: 7931216 [TBL] [Abstract][Full Text] [Related]
4. Chronic administration of the antidepressant-antipanic drug phenelzine and its N-acetylated analogue: effects on monoamine oxidase, biogenic amines, and alpha 2-adrenoreceptor function. McKenna KF; Baker GB; Coutts RT; Greenshaw AJ J Pharm Sci; 1992 Aug; 81(8):832-5. PubMed ID: 1383493 [TBL] [Abstract][Full Text] [Related]
5. GABA-elevating effects of the antidepressant/antipanic drug phenelzine in brain: effects of pretreatment with tranylcypromine, (-)-deprenyl and clorgyline. Todd KG; Baker GB J Affect Disord; 1995 Dec; 35(3):125-9. PubMed ID: 8749840 [TBL] [Abstract][Full Text] [Related]
6. Effects of the MAO inhibitor phenelzine on glutamine and GABA concentrations in rat brain. Paslawski TM; Sloley BD; Baker GB Prog Brain Res; 1995; 106():181-6. PubMed ID: 8584653 [TBL] [Abstract][Full Text] [Related]
7. The antidepressant phenelzine enhances memory in the double Y-maze and increases GABA levels in the hippocampus and frontal cortex of rats. Simpson SM; Hickey AJ; Baker GB; Reynolds JN; Beninger RJ Pharmacol Biochem Behav; 2012 Jul; 102(1):109-17. PubMed ID: 22503968 [TBL] [Abstract][Full Text] [Related]
8. Tissue levels and some pharmacological properties of an acetylated metabolite of phenelzine in the rat. Coutts RT; Mozayani A; Danielson TJ; Baker GB J Pharm Sci; 1991 Aug; 80(8):765-7. PubMed ID: 1791538 [TBL] [Abstract][Full Text] [Related]
9. Attenuation of the effects of oxidative stress by the MAO-inhibiting antidepressant and carbonyl scavenger phenelzine. Baker G; Matveychuk D; MacKenzie EM; Holt A; Wang Y; Kar S Chem Biol Interact; 2019 May; 304():139-147. PubMed ID: 30857888 [TBL] [Abstract][Full Text] [Related]
10. Effects of the antidepressant phenelzine on brain levels of gamma-aminobutyric acid (GABA). Baker GB; Wong JT; Yeung JM; Coutts RT J Affect Disord; 1991 Mar; 21(3):207-11. PubMed ID: 1648582 [TBL] [Abstract][Full Text] [Related]
11. Effects of the antidepressant/antipanic drug phenelzine on GABA concentrations and GABA-transaminase activity in rat brain. McManus DJ; Baker GB; Martin IL; Greenshaw AJ; McKenna KF Biochem Pharmacol; 1992 Jun; 43(11):2486-9. PubMed ID: 1610412 [TBL] [Abstract][Full Text] [Related]
12. Neurochemical effects of the monoamine oxidase inhibitor phenelzine on brain GABA and alanine: A comparison with vigabatrin. Todd KG; Baker GB J Pharm Pharm Sci; 2008 May; 11(2):14s-21s. PubMed ID: 19203467 [TBL] [Abstract][Full Text] [Related]
13. Effects of the antidepressant/antipanic drug phenelzine and its putative metabolite phenylethylidenehydrazine on extracellular gamma-aminobutyric acid levels in the striatum. Parent MB; Master S; Kashlub S; Baker GB Biochem Pharmacol; 2002 Jan; 63(1):57-64. PubMed ID: 11754874 [TBL] [Abstract][Full Text] [Related]
14. Task-dependent effects of the antidepressant/antipanic drug phenelzine on memory. Parent MB; Habib MK; Baker GB Psychopharmacology (Berl); 1999 Mar; 142(3):280-8. PubMed ID: 10208320 [TBL] [Abstract][Full Text] [Related]
15. Time-dependent changes in brain monoamine oxidase activity and in brain levels of monoamines and amino acids following acute administration of the antidepressant/antipanic drug phenelzine. Parent MB; Habib MK; Baker GB Biochem Pharmacol; 2000 May; 59(10):1253-63. PubMed ID: 10736426 [TBL] [Abstract][Full Text] [Related]
16. Overview of the Neuroprotective Effects of the MAO-Inhibiting Antidepressant Phenelzine. Matveychuk D; MacKenzie EM; Kumpula D; Song MS; Holt A; Kar S; Todd KG; Wood PL; Baker GB Cell Mol Neurobiol; 2022 Jan; 42(1):225-242. PubMed ID: 33839994 [TBL] [Abstract][Full Text] [Related]
17. A comparison of the acute effects of a tricyclic and a MAOI antidepressant on septal driving of hippocampal rhythmical slow activity. Zhu XO; McNaughton N Psychopharmacology (Berl); 1994 Mar; 114(2):337-44. PubMed ID: 7838927 [TBL] [Abstract][Full Text] [Related]
18. Behavioral effects of phenelzine in an experimental model for screening anxiolytic and anti-panic drugs: correlation with changes in monoamine-oxidase activity and monoamine levels. Griebel G; Curet O; Perrault G; Sanger DJ Neuropharmacology; 1998 Jul; 37(7):927-35. PubMed ID: 9776388 [TBL] [Abstract][Full Text] [Related]
19. Prior exposure to the elevated plus-maze sensitizes mice to the acute behavioral effects of fluoxetine and phenelzine. Holmes A; Rodgers RJ Eur J Pharmacol; 2003 Jan; 459(2-3):221-30. PubMed ID: 12524150 [TBL] [Abstract][Full Text] [Related]
20. Phenelzine causes an increase in brain ornithine that is prevented by prior monoamine oxidase inhibition. MacKenzie EM; Grant SL; Baker GB; Wood PL Neurochem Res; 2008 Mar; 33(3):430-6. PubMed ID: 17768678 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]